Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-18-741 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this prog...
Source: NIDDK Funding Opportunities - April 3, 2018 Category: Endocrinology Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Optional)
Funding Opportunity PA-18-052 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2017 Category: Research Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this prog...
Source: NIDDK Funding Opportunities - November 15, 2017 Category: Endocrinology Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
Funding Opportunity Number: PA-15-169 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) sta...
Source: Grants.gov - April 3, 2015 Category: Research Tags: Food and Nutrition Health Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
Funding Opportunity PA-15-169 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2015 Category: Research Source Type: funding
Request for Proposals: 2014 ASPIRE Young Investigator Research Awards in Endocrinology
Deadline for Application • Applications must be received by July 31, 2014, 11:59pm Eastern Daylight Time • Addenda, supplemental materials, changes, or updates will not be accepted after the deadline. • Notification of Awards recipients will be in September 2014 As competition for research funding opportunities increases, the ASPIRE program underscores Pfizer's commitment to supporting promising young investigators with an interest in advancing their academic research careers in Endocrinology. Mission The mission of the 2014 ASPIRE Young Investigator Research Awards in Endocr...
Source: ScanGrants feed - June 2, 2014 Category: Research Authors: Pfizer Source Type: funding
Acromegaly Clinical Research Fellowship Award
This award assists future endocrinologists in conducting endocrine research in Acromegaly. Recipients receive a stipend, one-year complimentary membership in The Endocrine Society and complimentary online access to four Society journals through 2014. Supported by Pfizer, Inc. Application Period: January 6 - February 28, 2014 Eligibility Criteria Applicants must meet the following requirements at the time of application: Must be an MD, MD/PhD, or DO degree (or equivalent clinical care certification) Must be enrolled in the first through third year of training in a U.S. adult or pediatric clinica...
Source: ScanGrants feed - January 27, 2014 Category: Research Authors: Endocrine Society Source Type: funding
Acromegaly Clinical Research Fellowship Award
We are currently accepting applications through January 30, 2013. The Acromegaly Clinical Research Fellowship Award assists future endocrinologists in conducting endocrine research in Acromegaly. This award is supported by Pfizer, Inc. Criteria: An independent panel of The Endocrine Society selects the recipients. Eligible applicants must: have an M.D., M.D./Ph.D. or D.O. degree (or equivalent clinical care certification) be enrolled in the first through third year of training in a U.S. adult or pediatric clinical endocrinology program The recipient will receive a stipend, one-year complime...
Source: ScanGrants feed - January 28, 2013 Category: Research Authors: Endocrine Society Source Type: funding
